GRILLiT was founded on the concept of delivering a fast-casual dining experience with fresh, nutritious home-style cooking. Leveraging more than four decades of experience in the food industry, the founders of GRILLiT established this unique business model to satisfy the ever-increasing demand for delicious and healthy food while providing the perfect ambiance for guest to relax and enjoy great cuisine.
Cardium Therapeutics, Inc. (CXM) Builds Diverse Portfolio with Broad Commercialization Opportunities
It’s not something you’d expect to find in a regenerative medicine company’s portfolio, but Cardium Therapeutics’ To Go Brands healthy nutraceutical supplement business is complementary to the company’s overarching mission of meeting unmet medical needs as part of an individual’s overall health and wellness.
Cardium in October 2012 acquired the assets, business, and product portfolio of To Go Brands, which develops and markets more than 25 products including nutraceutical powder mixes, supplements, and chews to support healthy lifestyles.
DoMark International Inc. (DOMK) Reports Strong Demand for New IRCharger Cover
DoMark International, a leader in infrared/solar charging systems for Apple (AAPL) and Samsung (KOSCOM:SSNFL) devices, today announced that it has received 158,000 orders for its new IRCharger case for Apple iPhones and Samsung Galaxy Slll and S4 smartphones prior to its upcoming global launch date.
“Our global distribution partners have been receiving great interest for the product from retailers and we are expecting to be able to announce many more orders shortly,” Domark CEO Andy Ritchie said.
The Aristocrat Group Corp. (ASCC) Launches Brand-Building Wholesale Initiative
StreamTrack, Inc. (STTK) Successfully Addresses the Fast Growing Mobile Market
StreamTrack, California-based provider of audio and video streaming services to broadcasters, is known for having made it profitable for radio stations to broadcast over the Internet. The company’s RadioLoyalty platform technology allows video advertisements to be inserted and controlled, giving advertisers a proven high-powered way to reach select audiences. The company already serves over a thousand stations, and expects its proprietary platform to continue growing in popularity.
Ventripoint Diagnostics, Inc. (VPTDF) Seeks to Expand AngeloVMS™ Applications, Triple Sales by 2014
Ventripoint Diagnostics is the creator of what company management believes to be the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company created the blueprint to achieve its application expansion and goals for continued financial growth, supported by key management.
The Guitammer Company (GTMM) and Obutto Join Forces to Deliver Immersive 4D Gaming Worldwide
The Guitammer Company, a leader in low frequency sound and creator of the award-winning line of ButtKicker®-brand low frequency audio transducers that provide an immersive entertainment experience, has teamed up with Obutto to expand joint marketing efforts to include sim racers and flight sim customers in China as well as distribution in Canada and Europe.
GNCC Capital, Inc. (GNCP) Ester Basin Gold Exploration Properties
Nevada-based gold and silver exploration company GNCC Capital holds a number of gold and silver properties in Arizona, including the Ester Basin property in west central Arizona. The property consists of 5 unpatented lode mining claims, covering 100 acres, on land administered by the Bureau of Land Management. Gold mineralization is found in silicified quartz breccia zones throughout the property, and there are numerous shafts, glory holes, and other historic mine workings.
Mabwe Minerals, Inc. (MBMI) Lined Up for Major Production at Dodge Mine
GlobalWise Investments, Inc. (GWIV) Uses the Cloud to Bring Technologies Together
As one new technological direction after another is spawned, one thing is becoming clear: It is the combination of new technologies that results in the greatest change. Cloud technology is a prime example of this fact, since it is integrated with, or even enables, many other technologies. One of the greatest benefits of cloud-based applications is the ability to access both data and functionality anywhere and anytime. This leads, naturally, to a strong relationship with mobile device technology, a symbiotic relationship that encourages both cloud and mobile developments.
Advaxis, Inc. (ADXS) Submits Request for Orphan Drug Designation
Today, Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported the submission of an application for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated head and neck cancer. It is currently estimated that there are 50,000 new cases of head and neck cancer annually, with about 15,000 deaths.
The Aristocrat Group Corp. (ASCC) Outlines Vodka Distribution Strategy
Today before the opening bell, the Aristocrat Group announced that it will be handling the distribution of its two new vodka brands through the wholly owned subsidiary TOP Shelf Distributing. This move was made to maximize profit potential in the booming $21.3 billion U.S. spirits industry.
Advaxis, Inc. (ADXS) Encourages Shareholders to Vote in Favor of Proposals 2 and 3
Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, earlier today issued a letter to stockholders recommending that they vote ‘FOR’ Proposals No. 2 and No. 3 of its definitive proxy statement on Schedule 14A as filed with the SEC. The letter provides shareholders with compelling reasons why these proposals are in their best interests.
The full text of the letter follows:
Dear Fellow Stockholders,
Rainbow Coral Corp. (RBCC) Pursues Expansion and Explores New Funding
Advaxis, Inc. (ADXS) Files for Orphan Drug Designation for ADXS-HPV Candidate
Advaxis, a clinical-stage biotech company focused on developing the next generation of immunotherapies for cancer and infectious diseases, has submitted an application for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) Office for ADXS-HPV, the company’s lead drug candidate for the treatment of invasive cervical cancer.
“We are optimistic about our request for Orphan Drug Designation for ADXS-HPV in the indication of invasive cervical cancer,” Dr. Robert Petit, chief scientific officer of Advaxis stated in the press release.